Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Obesity 1

Interventions

Metformin 21Inositol 13Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2salicylsalicylic acid 1mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × mirabegron × 1 year × Clear all
NCT03049462 2026-06-01

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡